| Distinct actin cytoskeleton behaviour in primary and immortalised T-cells H Colin-York, S Kumari, L Barbieri, L Cords, M Fritzsche Journal of cell science 133 (5), jcs232322, 2020 | 33 | 2020 |
| Cancer-associated fibroblast classification in single-cell and spatial proteomics data L Cords, S Tietscher, T Anzeneder, C Langwieder, M Rees, N de Souza, ... Nature communications 14 (1), 4294, 2023 | 26 | 2023 |
| Missing-in-Metastasis/Metastasis suppressor 1 regulates B cell receptor signaling, B cell metabolic potential, and T cell-independent immune responses AV Sarapulov, P Petrov, S Hernández-Pérez, V Šuštar, E Kuokkanen, ... Frontiers in immunology 11, 599, 2020 | 9 | 2020 |
| Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer L Cords, S Engler, M Haberecker, JH Rüschoff, H Moch, N de Souza, ... Cancer Cell, 2024 | 8 | 2024 |
| Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype S Hiltbrunner, L Cords, S Kasser, SN Freiberger, S Kreutzer, ... Nature Communications 14 (1), 5154, 2023 | 5 | 2023 |
| Single-cell Analysis of Cancer-associated Fibroblast Heterogeneity with a Focus on Spatial Distribution and Clinical Implications L Cords Universität Zürich, 2023 | | 2023 |
| A Cancer-Associated Fibroblast Classification Framework for Single-Cell Data L Cords, S Tietscher, T Anzeneder, C Langwieder, M Rees, N de Souza, ... bioRxiv, 2022.12. 14.520398, 2022 | | 2022 |
| Acquired resistance to anti-PD1 therapy in patients with NSCLC reveals changes in T cell phenotypes and MET amplification S Hiltbrunner, L Cords, S Kasser, SN Freiberger, S Kreutzer, ... bioRxiv, 2022.04. 08.487590, 2022 | | 2022 |
| Resistance mechanisms in non-small cell lung cancer patients upon anti-PD1 therapy S Hiltbrunner, L Cords, S Kasser, S Freiberger, S Kreutzer, N Toussaint, ... ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 195-195, 2020 | | 2020 |
